高盛-恒瑞医药(600276.SS):业绩回顾:产品销售符合预期,业绩表现更优,重申创新药全年30%+增长目标-HengruiMedicine(600276.SS):EarningsReview:Productsalesin-linewithbetterearnings;Reiteratefull-year30%+growthforinnovativ-20260423【7页】

发表回复

后才能评论